These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22525503)

  • 1. [Subcellular proteomic analysis of Tetrazanbigen on human hepatocellular carcinoma cell line QGY-7701].
    Yuan YH; Yang XL; Li W; Zheng XH; Gu R; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):908-11. PubMed ID: 22525503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].
    Chang XJ; Lu YY; Bai WL; Chen Y; An LJ; Zhou L; Wang H; Wu Y; Liu Z; Lou M; Zeng Z; Su SH; Yang YP
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):759-63. PubMed ID: 22409849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy.
    Shao YY; Wu CH; Lu LC; Chan SY; Ma YY; Yen FC; Hsu CH; Cheng AL
    J Hepatol; 2014 Feb; 60(2):313-8. PubMed ID: 24036008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
    Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
    Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
    Yau T; Yao TJ; Chan P; Ng K; Fan ST; Poon RT
    Cancer; 2008 Nov; 113(10):2742-51. PubMed ID: 18853421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study.
    Mazzaferro V; Sposito C; Bhoori S; Romito R; Chiesa C; Morosi C; Maccauro M; Marchianò A; Bongini M; Lanocita R; Civelli E; Bombardieri E; Camerini T; Spreafico C
    Hepatology; 2013 May; 57(5):1826-37. PubMed ID: 22911442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
    Chung IK; Park MJ; Kwon KT; Park YD; Chung YJ; Jeon SW; Lee MK; Seo HE; Lee YD; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
    Korean J Hepatol; 2005 Dec; 11(4):371-80. PubMed ID: 16380666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
    J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
    Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of staging systems to predict survival in hepatocellular carcinoma.
    Pascual S; Zapater P; Such J; García-Herola A; Sempere L; Irurzun J; Palazón JM; Carnicer F; Pérez-Mateo M
    Liver Int; 2006 Aug; 26(6):673-9. PubMed ID: 16842323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival factors after resection of small hepatocellular carcinoma.
    Wu FS; Zhao WH; Liang TB; Ma ZM; Teng LS; Wang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):379-84. PubMed ID: 16109520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.